Cargando…

Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia

BACKGROUND: Acute limb ischemia (ALI) is associated with significant morbidity and mortality. Novel anticoagulants reduce adverse events among patients with peripheral artery disease, though the potential effect of these therapies is unclear in patients with ALI. The present study thus sought to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freeman, Scott, Williams, Piper, Barón, Anna E., Plomondon, Mary E., Waldo, Stephen W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197665/ https://www.ncbi.nlm.nih.gov/pubmed/35712525 http://dx.doi.org/10.1155/2022/3786815

Ejemplares similares

Worth an Arm and a Leg: The Critical Importance of Limb Ischemia
por: Valle, Javier A., et al.
Publicado: (2018)

Characteristics of the Quality Improvement Content of Cardiac Catheterization Peer Reviews in the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
por: Doll, Jacob A., et al.
Publicado: (2019)

Anticoagulation With Platelet Transfusions for Acute Limb Ischemia With Severe Thrombocytopenia
por: Shakfeh, Khalid, et al.
Publicado: (2023)

Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program
por: Waldo, Stephen W., et al.
Publicado: (2022)

Clinical Characteristics and Outcomes Among Patients Undergoing High‐Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
por: Kovach, Christopher P., et al.
Publicado: (2021)

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia
por: Siracuse, Jeffrey J, et al.
Publicado: (2014)

Hospital Readmissions Following Endovascular Therapy for Critical Limb Ischemia: Associations With Wound Healing, Major Adverse Limb Events, and Mortality
por: Reed, Grant W., et al.
Publicado: (2016)

Acute Upper Limb Ischemia: Prompt Surgery and Long-Term Anticoagulation Prevent Limb Loss and Debilitation
por: Harnarayan, Patrick, et al.
Publicado: (2021)

COVID-19-Associated Acute Limb Ischemia in a Patient on Therapeutic Anticoagulation
por: Gubitosa, James C, et al.
Publicado: (2020)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

A pilot study to assess the learning environment and use of reliability enhancing work practices in VHA cardiac catheterization laboratories
por: Gilmartin, Heather M., et al.
Publicado: (2020)

Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program
por: Keach, Joseph Walker, et al.
Publicado: (2020)

Acute limb ischemia in COVID-19 patients despite therapeutic anticoagulation: Experience from Africa
por: Alemayehu, Fikremariam Melkeneh, et al.
Publicado: (2023)

Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New‐Onset Heart Failure
por: McGuinn, Erin, et al.
Publicado: (2021)

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study
por: Long, Andrea L, et al.
Publicado: (2010)

A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19()
por: Patel, Purva, et al.
Publicado: (2023)

Adverse Effect of Circadian Rhythm Disorder on Reparative Angiogenesis in Hind Limb Ischemia
por: Tsuzuki, Kazuhito, et al.
Publicado: (2021)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events
por: Smolderen, Kim G., et al.
Publicado: (2022)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Temporal Trends and Site Variation in High‐Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program
por: Bricker, Rory S., et al.
Publicado: (2019)

Successful limb salvage by endovascular treatment for critical limb ischemia subsequent to acute limb ischemia
por: Nomura, Tetsuya, et al.
Publicado: (2019)

Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
por: Morrison, Justin, et al.
Publicado: (2019)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Critical Limb Ischemia
por: Schanzer, Andres, et al.
Publicado: (2010)

Acute Limb Ischemia
por: Obara, Hideaki, et al.
Publicado: (2018)

Acute limb ischemia
por: Rosenberg, Hans, et al.
Publicado: (2023)

The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia
por: McGuinness, Brandon, et al.
Publicado: (2022)

Variation in adverse drug events of opioids in the United States
por: Liu, Edward Y., et al.
Publicado: (2023)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Potential of Novel EPO Derivatives in Limb Ischemia
por: Joshi, Dhiraj, et al.
Publicado: (2012)

Direct medical costs of adverse events in Dutch hospitals
por: Hoonhout, Lilian HF, et al.
Publicado: (2009)

Assessment of costs associated with adverse events in patients with cancer
por: Wong, William, et al.
Publicado: (2018)

Costs associated with adverse events among acute patients
por: Kjellberg, Jakob, et al.
Publicado: (2017)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013)

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
por: Maura, Géric, et al.
Publicado: (2018)

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Covid-19 responsible for acute limb ischemia twice at 2 different stages in a patient on anticoagulation: A case report
por: Banana, Youssef, et al.
Publicado: (2021)

Pathophysiology of chronic limb ischemia
por: Simon, F., et al.
Publicado: (2018)

COVID-19 and limb ischemia
por: Wood, Jeffrey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_goob295gepghjq1ukg57b9062m